Annual report pursuant to Section 13 and 15(d)

Equity Compensation Plans (Tables)

v3.20.1
Equity Compensation Plans (Tables)
12 Months Ended
Mar. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock Option Awards

The following table summarizes information about the Company's stock option awards during fiscal 2020, fiscal 2019 and fiscal 2018:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

Shares

 

 

Average

 

 

Weighted

 

Aggregate

 

 

 

Under

 

 

Exercise

 

 

Average Remaining

 

Intrinsic

 

 

 

Option

 

 

Price

 

 

Contractual Term

 

Value

 

Outstanding at April 1, 2017

 

 

69

 

 

 

20.26

 

 

 

 

 

 

 

Exercised

 

 

—

 

 

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2018

 

 

69

 

 

 

20.26

 

 

 

 

 

 

 

Exercised

 

 

(19

)

 

 

15.89

 

 

 

 

 

 

 

Cancelled

 

 

(11

)

 

 

33.02

 

 

 

 

 

 

 

Outstanding at March 31, 2019

 

 

39

 

 

 

18.76

 

 

 

 

 

 

 

Exercised

 

 

(2

)

 

 

15.25

 

 

 

 

 

 

 

Outstanding at March 31, 2020

 

 

37

 

 

 

18.92

 

 

2.07 years

 

$

—

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested or expected to vest at March 31, 2020

 

 

37

 

 

 

18.92

 

 

2.07 years

 

 

—

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at March 31, 2020

 

 

37

 

 

 

18.92

 

 

2.07 years

 

 

—

 

Stock Options Outstanding

The following table summarizes information about stock options outstanding at March 31, 2020:

 

Exercise Price

 

Options Outstanding

at March 31, 2020

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining

Contractual Life

(in years)

 

$18.65

 

 

33

 

 

$

18.65

 

 

 

2.17

 

$21.19

 

 

4

 

 

 

21.19

 

 

 

1.17

 

$18.65-21.19

 

 

37

 

 

 

18.92

 

 

 

2.07

 

Schedule of Restricted Stock Awards

The following table summarizes information about the Company's restricted stock awards during fiscal 2020, fiscal 2019 and fiscal 2018:

 

 

 

Restricted Stock

 

 

Weighted Average

Grant Date Fair Value

 

 

Aggregate

Intrinsic Value

 

Non-vested at April 1, 2017

 

 

120

 

 

 

21.96

 

 

 

 

 

Granted

 

 

59

 

 

 

23.03

 

 

 

 

 

Vested

 

 

(25

)

 

 

20.44

 

 

 

 

 

Forfeited

 

 

(28

)

 

 

25.27

 

 

 

 

 

Non-vested at March 31, 2018

 

 

126

 

 

 

22.02

 

 

 

 

 

Granted

 

 

53

 

 

 

30.08

 

 

 

 

 

Vested

 

 

(28

)

 

 

20.38

 

 

 

 

 

Forfeited

 

 

(2

)

 

 

22.83

 

 

 

 

 

Non-vested at March 31, 2019

 

 

149

 

 

 

25.19

 

 

 

 

 

Granted

 

 

83

 

 

 

22.95

 

 

 

 

 

Vested

 

 

(38

)

 

 

23.17

 

 

 

 

 

Forfeited

 

 

(45

)

 

 

22.52

 

 

 

 

 

Non-vested at March 31, 2020

 

 

149

 

 

 

25.26

 

 

$

—